Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy

por Velling, P, Skowasch, D, Pabst, S, Jansen, E, Tuleta, I, Grohé, C
Publicado 2011

Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease

por Pabst, S, Theis, B, Gillissen, A, Lennarz, M, Tuleta, I, Nickenig, G, Skowasch, D, Grohé, C
Publicado 2009

ADAM33 gene polymorphisms in chronic obstructive pulmonary disease

por Pabst, S, Touron, C Pizarro, Gillissen, A, Lennarz, M, Tuleta, I, Nickenig, G, Skowasch, D, Grohé, C
Publicado 2009

Systemically Administered Ligands of Toll-Like Receptor 2, -4, and -9 Induce Distinct Inflammatory Responses in the Murine Lung

por Ehrentraut, H., Meyer, R., Schwederski, M., Ehrentraut, S., Velten, M., Grohé, C., Knuefermann, P., Baumgarten, G., Boehm, O.
Publicado 2011

The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report

por Hardenberg, M.C., Patel, B., Matthews, C., Califano, R., Garcia Campelo, R., Grohe, C., Hong, M.H., Liu, G., Lu, S., de Marinis, F., Pérol, M., Soo, R.A., Stiles, B.M., Tiseo, M., Tsuboi, M.
Publicado 2022

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer

por Kron, A, Alidousty, C, Scheffler, M, Merkelbach-Bruse, S, Seidel, D, Riedel, R, Ihle, M A, Michels, S, Nogova, L, Fassunke, J, Heydt, C, Kron, F, Ueckeroth, F, Serke, M, Krüger, S, Grohe, C, Koschel, D, Benedikter, J, Kaminsky, B, Schaaf, B, Braess, J, Sebastian, M, Kambartel, K -O, Thomas, R, Zander, T, Schultheis, A M, Büttner, R, Wolf, J
Publicado 2018